You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

NORPRAMIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Norpramin, and when can generic versions of Norpramin launch?

Norpramin is a drug marketed by Validus Pharms and is included in one NDA.

The generic ingredient in NORPRAMIN is desipramine hydrochloride. There are nine drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the desipramine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Norpramin

A generic version of NORPRAMIN was approved as desipramine hydrochloride by ACTAVIS TOTOWA on June 5th, 1987.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for NORPRAMIN?
  • What are the global sales for NORPRAMIN?
  • What is Average Wholesale Price for NORPRAMIN?
Summary for NORPRAMIN
Drug patent expirations by year for NORPRAMIN
Drug Prices for NORPRAMIN

See drug prices for NORPRAMIN

Recent Clinical Trials for NORPRAMIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Stanford UniversityPhase 4
Albert Einstein College of Medicine of Yeshiva UniversityN/A
Albert Einstein College of MedicineN/A

See all NORPRAMIN clinical trials

Pharmacology for NORPRAMIN

US Patents and Regulatory Information for NORPRAMIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-007 Feb 11, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-004 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-003 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-006 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for NORPRAMIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-001 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-004 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-006 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-007 Feb 11, 1982 ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-005 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
Validus Pharms NORPRAMIN desipramine hydrochloride TABLET;ORAL 014399-003 Approved Prior to Jan 1, 1982 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for NORPRAMIN

See the table below for patents covering NORPRAMIN around the world.

Country Patent Number Title Estimated Expiration
Spain 267641 ⤷  Sign Up
France 1445454 Nouveaux dérivés d'iminodibenzyle et leur préparation ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.